Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease
Eur Respir J
.
2018 Apr 4;51(4):1800410.
doi: 10.1183/13993003.00410-2018.
Print 2018 Apr.
Authors
Herbert Decaluwé
1
,
Christophe Dooms
2
,
Paul De Leyn
1
,
Pascal Thomas
3
,
Ramon Rami-Porta
4
Affiliations
1
Dept of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
2
Dept of Pneumology, University Hospitals Leuven, Leuven, Belgium.
3
Dept of Thoracic Surgery, Lung Transplantation and Diseases of the Esophagus, North University Hospital, Marseille, France.
4
Dept of Thoracic Surgery, Hospital Universitari Mutua Terrassa, Terrassa, Spain.
PMID:
29618606
DOI:
10.1183/13993003.00410-2018
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*